Identifying therapeutics which can be repurposed for the treatment of Myelodysplastic Syndrome and other Bone Marrow Failure Disorders

Researchers

Grant status

Completed

Grant start date

14/09/2018

Grant funding

  • 2018: $204,637 from Maddie Riewoldt's Vision

Updated:  27 June 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers